Drug for antagonizing replication of porcine reproductive and respiratory syndrome virus and application thereof

Patent metadata

Field	Value
Publication number	US-2024091172-A1
Application number	US-202017767616-A
Country	US
Kind code	A1
Filing date	Jun 3, 2020
Priority date	Oct 8, 2019
Publication date	Mar 21, 2024
Grant date	—

Abstract

A drug for antagonizing the replication of porcine reproductive and respiratory syndrome virus (PRRSV) and an application thereof. By using a viral infection test, a drug which antagonizes PRRSV—xanthohumol—is discovered for the first time from among a natural drug library of 386 plant sources. Xanthohumol can effectively inhibit PRRSV replication on both Marc-145 and PAM cells. Five xanthohumol derivatives having different molecular structures are artificially synthesized, and it is discovered that a derivative Xn-4 has the strongest inhibitory effect on virus replication in vitro. Test results of artificial infection and drug therapy in piglets show that the Xn-4 can effectively inhibit PRRSV viremia, relieve clinical symptoms of infected pigs, and significantly reduce lung inflammation and pathological damage.

First claim

1 . A method for preventing or treating porcine reproductive and respiratory syndrome comprising administering a drug comprising xanthohumol and/or a derivative thereof.

2 . The method of claim 1 , wherein the structure of the xanthohumol is shown in formula (I);

the structure of the xanthohumol derivative is shown in formula (II):

where R 1 is H or CH 3 , R 2 is H or CH 3 , R 3 is H or OH, and R 4 is H or NO 2 .

3 . A xanthohumol derivative, having a structure shown in formula (III):

4 . A preparation method of the xanthohumol derivative of claim 3 , comprising the following steps:

(1) adding m-trisphenol, isopropyl ether, acetonitrile and anhydrous zinc chloride into a reaction vessel, controlling the temperature at 0-5° C., and keeping stirring; introducing dry hydrogen chloride gas until the reaction solution becomes clear from turbidity; continuing to introduce the hydrogen chloride gas for producing a large amount of white solid; after gas introduction, immediately placing the reaction solution in a refrigerator at −10° C. overnight for crystallization; the next day, taking out and filtering the reaction solution, and washing the filter cake with isopropyl ether once; taking out the filter cake, adding water to fully disperse, starting heating, and carrying out atmospheric distillation to remove the residual isopropyl ether from the product; then continuing to heat up to 100° C. to reflux for producing a large amount of white solid, cooling the product to normal temperature, filtering the product, washing the filter cake with water and then drying the filter cake to obtain intermediate 1;
(2) adding the intermediate 1, acetone, anhydrous potassium carbonate and dimethyl sulfate into the reaction vessel, starting mechanical stirring, heating to reflux until the reaction is complete, filtering the reaction solution, washing the filter cake twice with acetone, concentrating the filtrate to obtain a solid, then washing the solid with petroleum ether and ethyl acetate (V:V) of 10:1, and carrying out filtering and drying to obtain intermediate 2; and
(3) adding potassium hydroxide to methanol, adding the intermediate 2 after cooling to room temperature, then adding p-hydroxybenzaldehyde, and stirring the mixture until the reaction is complete; adding the reaction solution to water, filtering the reaction solution, taking out the filter cake, adding absolute ethanol, heating the product to reflux, cooling the product to 0° C., and carrying out filtering and drying to obtain the target product.

5 . A method for preventing or treating porcine reproductive and respiratory syndrome comprising administering a drug comprising the xanthohumol derivative of claim 3 .

6 . A drug for antagonizing porcine reproductive and respiratory syndrome virus, containing xanthohumol or the xanthohumol derivative of claim 3 .

Assignees

• Univ Nanjing Agricultural

Inventors

• Jiang Ping
• Liu Xuewei
• Bai Juan
• Zhang Junren
• Wang Xianwei
• Li Yufeng

Classifications

• C12N7/00

  Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00) · CPC title

• C07D471/04

  Ortho-condensed systems · CPC title

• C12N15/86

  Viral vectors · CPC title

• C07D487/04

  Ortho-condensed systems · CPC title

• A61K45/06

  Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title